# Epoprostenol in Pulmonary Embolism

> **NCT01014156** · PHASE4 · COMPLETED · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 14 (actual)

## Conditions studied

- Acute Pulmonary Embolism

## Interventions

- **DRUG:** epoprostenol

## Key facts

- **NCT ID:** NCT01014156
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2009-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01014156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01014156, "Epoprostenol in Pulmonary Embolism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01014156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*